Featured Story

FDA approves diagnostic to spot blood cancer-causing virus

Santa Ana, CA-based MP Biomedicals has nabbed FDA approval for the first supplemental test designed to better identify blood donors that have tested positive for human T cell lymphotropic virus.

BacterioScan completes oversubscribed Series A financing round for in vitro UTI test

In vitro diagnostics outfit BacterioScan closed an oversubscribed Series A financing round to support development of its next-generation, rapid diagnostic test for urinary tract infection.

Roche expands use of next-gen blood tests for organ and tissue screening

Roche got a green light from U.S. regulatory authorities to expand the use of two tests from its cobas assay line used to detect serious viral infections like HIV, hepatitis B and C and West Nile.

Ortho-Clinical Diagnostics launches Astute Medical's acute kidney injury test in U.S. hospitals

Ortho-Clinical Diagnostics rolled out Astute Medical's test for acute kidney injury in U.S. hospitals, chalking up a milestone in the companies' push to commercialize the product.

Epigenomics scores Chinese marketing approval for innovative colorectal cancer test

Epigenomics won marketing approval in China for its next-generation colorectal cancer test, moving the company forward on its path toward global commercialization for the product and helping it compete in an increasingly competitive playing field.